Unilever Stock News

Futures Recover From Wednesday Rout As Yields, VIX Stabilize Whereas the stock plunge on Tuesday could be blamed on surging rates, the repeat tumble on Wednesday took place as Treasury yields dropped sharply, so with markets at a loss how to read rate signals, so far this morning S&P e-mini futures have rebounded by 23 points ot 0.5% from yesterday''s low just above 4,500 - a key support level according to JPMorgan - as volatility eased and global bond yields appear to have stabilize for now, and hours after China''s latest easing measure when Beijing lowered mortgage lending benchmark rates on Thursday as monetary authorities step up efforts to prop up the slowing economy. 10Y Treasuries rose from session lows, last trading at 1.84%, European stocks fluctuated as the dollar index was little changed and crude oil slipped after a three-day rally as gold held around a two-month high. China''s cut to the one-year and five-year loan prime rates (LPR) which lowered the one-year LPR by 10 basis points to 3.70% from 3.80% - the second consecutive monthly cut - and the five-year LPR by 5 basis points to 4.60% from 4.65%, its first cut since April 2020. ... followed surprise cuts by China''s central bank on Monday to its short- and medium-term lending rates, and came days after the central bank''s vice governor flagged more moves ahead.

Unilever decides that it will not raise its offer of $68 billion for Glaxo's (GSK) Consumer Healthcare business.

Influential British fund manager Terry Smith attacked Unilever's failed 50 billion pound ($68.2 billion) bid for GSK's Consumer Health assets as a "near death experience" and urged Unilever management

Shares in Unilever inched roughly 2% higher on Thursday after the consumer goods giant said it would not raise its rejected £50 billion ($68 billion) offer for GlaxoSmithKline's consumer health care

The reasons to consider this stock go well beyond its 4% dividend yield and deflated share price.

Glaxo says it will stick to its plan to separately list the consumer healthcare business in mid-2022.

Shares in Unilever PLC (LSE:ULVR) rose and GlaxoSmithKline PLC (LSE:GSK) fell after the Anglo-Dutch group said late yesterday it was abandoning its pursuit of the GSK Consumer Healthcare joint v

Shares in consumer goods giant Unilever inched roughly 2% higher on Thursday after it said late on Wednesday it would not raise its rejected 50 billion pound ($68 billion) offer for GlaxoSmithKline's

Unilever PLC (LSE:ULVR) has abandoned its pursuit of the Consumer Healthcare joint venture owned by GlaxoSmithKline PLC (LSE:GSK) and Pfizer Inc (NYSE:PFE) after criticism from investors. The An

Other consumers goods giants including Nestle, Danone, and Unilever have also warned of price hikes stretching into 2022.

A day after a sharp drop, shares of the European consumer products and food maker rose. Only it wasn''t a simple rebound -- Unilever did an about-face.

A group of investors in Unilever said on Thursday they had filed a fresh resolution urging the company to fix a "crucial blind spot" in its strategy and set ambitious targets to sell healthier foods.

Unilever, the maker of Vaseline skin care products and Dove soap, says it wont increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKlines consumer healthcare unit that was rejected last week

Unilever ADRs Bounce Back After Co. Commits to Financial Discipline Morningstar.com

Unilever says data shared by GSK suggests fundamental value of business no higher than offer